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Objective.We conducted a systematic review to investigate the cross-sectional and prospective associations
of accelerometer-measured total sedentary time and breaks in sedentary time with individual cardiometabolic
biomarkers in adults ≥18 years of age.
Methods.OvidMedline, Embase,Webof Science and theCochrane Librarywere searched for studiesmeeting the
inclusion criteria. Due to inconsistencies in the measurement and analysis of sedentary time, data was synthesised
and presented narratively rather than as a meta-analysis.
Results. Twenty-nine studieswere included in the review; twenty-eight reported on total sedentary time and six
on breaks in sedentary time. Therewas consistent evidence from cross-sectional data of an unfavourable association
between total sedentary time and insulin sensitivity. There was also some evidence that total sedentary time was
unfavourably associated with fasting insulin, insulin resistance and triglycerides. Furthermore, there was some ev-
idence from cross-sectional data of a favourable association between breaks in sedentary time and triglycerides.
Conclusion. Total sedentary time was consistently shown to be associated with poorer insulin sensitivity, even
after adjusting for time spent in physical activity. This ﬁnding supports the proposed association between sedentary
time and the development of Type 2 diabetes and reinforces the need to identify interventions to reduce time spent
sedentary.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Physical activity is considered to be central to the prevention and
management of Type 2 diabetes because of its potential to improve
glycaemic control, lipid proﬁles and blood pressure, and in combination
with dietary intervention, to aid weight loss and maintenance (Colberg
et al., 2010). However, fewer people with Type 2 diabetesmeet physical
activity recommendations (at least 150 min of moderate-to-vigorous-
intensity physical activity [MVPA] per week) than in the general popu-
lation (Morrato et al., 2007) and people with Type 2 diabetes often ﬁnd
it difﬁcult to increase their physical activity levels by a sufﬁcient amount
to improve cardiometabolic health outcomes (Andrews et al., 2011).
Therefore, alternative interventions for improving cardiometabolic
health may be required.
Recent interest has focussed on the potential role of sedentary
behaviour in the development of chronic diseases. Sedentary behaviour
is deﬁned as anywaking behaviour characterised by an energy expendi-
ture ≤1.5 metabolic equivalents (METs) whilst in a sitting or reclining
posture. Sedentary behaviour is distinct from physical inactivity,
which is deﬁned as failure to meet the current physical activity recom-
mendations (Sedentary Behaviour Research, 2012).
In previous systematic reviews, more time spent in sedentary
behaviours has been shown to be adversely associated with both risk
of chronic diseases and with poorer cardiometabolic health (de
Rezende et al., 2014; Edwardson et al., 2012; Wilmot et al., 2012).
However, the majority of the studies included in these reviews
measured sedentary time with self-report questionnaires, which are
susceptible to recall and social desirability bias (Clark et al., 2009;
Corder et al., 2007). Therefore, the aim of the current systematic review
is to investigate the cross-sectional and prospective associations of
accelerometer-measured total sedentary time and breaks in sedentary
time with individual cardiometabolic biomarkers in adults ≥18 years
of age.
Methods
Search strategy and inclusion criteria
Ovid Medline, Embase, Web of Science and the Cochrane Library were
searched for relevant publications (24 June 2014). The search strategy used in
Ovid Medline is shown in Supplementary Methods and the same search terms
were used in the other databases.
To be included in the systematic review, studies had to meet the follow-
ing inclusion criteria: (1) written in English; (2) cross-sectional or prospec-
tive study design; (3) report data on adults ≥18 years of age; (4) use an
accelerometer to measure total sedentary time and/or breaks in sedentary
time; (5) measure at least one cardiometabolic biomarker of interest
(fasting plasma glucose, fasting insulin, 2-hour plasma glucose, insulin sen-
sitivity, homeostasis model assessment of insulin resistance [HOMA-IR],
total cholesterol, high-density lipoprotein cholesterol [HDL-cholesterol],low-density lipoprotein cholesterol [LDL-cholesterol] and triglycerides);
and (6) report cross-sectional and/or prospective associations of total sed-
entary time and/or breaks in sedentary time with at least one cardiometa-
bolic biomarker of interest. Studies were excluded if they deﬁned
sedentary behaviour as failure to meet the current physical activity
recommendations.
Titles and abstracts were independently reviewed by LB and CF for re-
trieval of full-text articles meeting the inclusion criteria. If any uncertainty
or disagreement existed, the full-text was obtained for discussion with AC.
Studies that did not meet the inclusion criteria were disregarded at this
stage.
Quality assessment
LB and CF developed a quality assessment tool with reference to the
Newcastle-Ottawa Scale (Wells et al., 2014) and the STROBE (Strengthening
the Reporting of Observational studies in Epidemiology) Statement (von Elm
et al., 2008). The total score availablewas 7 points: 1 point for reporting a prospec-
tive association(s), 1 if analysis adjusted for MVPA (studies reporting on total
sedentary time) or MVPA and total sedentary time (studies reporting on breaks
in sedentary time), 1 if analysis adjusted for body mass index (BMI) and/or
waist circumference (WC), 1 if analysis adjusted for sex (if males and females
combined), age and ethnicity, 1 for anobjectivemeasure of the health outcome(s),
1 for at least 7 valid days (≥10 h) of accelerometer wear time (Matthews et al.,
2002) and 1 for an adequate description of the population, including sex, age,
BMI and metabolic health. Two authors (LB and AC) independently assessed all
studies for quality and any discrepancies were discussed with CF. A score of 5 to
7 was considered high quality, 3 or 4 moderate quality and 0 to 2 poor quality.
Data extraction and synthesis
Two authors (LB and AC) independently extracted data using a data ex-
traction form developed for this review. The primary outcomes were the
cross-sectional and prospective associations of total sedentary time and
breaks in sedentary time with individual cardiometabolic biomarkers (Pear-
son correlation coefﬁcients, regression coefﬁcients and P for trend). Due to
inconsistencies in the way in which sedentary time was measured, deﬁned
and analysed, data was synthesised and presented narratively rather than
as a meta-analysis.
The ﬁndings for each cardiometabolic biomarker were interpreted on
the following basis: there was no evidence of an association if more than
50% of the cross-sectional and prospective studies reported no association;
the evidence for an association was inconclusive if 50% of the studies re-
ported no association and 50% reported a positive or negative association;
there was some evidence of an association if more than 50% of the studies
reported a positive or negative association; and there was consistent evi-
dence of an association if all of the studies reported a positive or negative
association.
Results
The initial search identiﬁed 4858 studies (Fig. 1). Twenty-nine studies
were included in the systematic review; twenty-eight reported on total
Fig. 1. Flow diagram of study selection process, from initial search to included studies. N, number of studies.
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Four studies were prospective(9, 10, 20, 29) and the remaining were cross-
sectional. Twenty-two studies adjusted for MVPA and total sedentary
time (if applicable), fourteen adjusted for BMI and/or WC and eight
adjusted for sex (if applicable), age and ethnicity. However, only ﬁve
studies adjusted for all of these confounding variables(12, 16, 18, 22, 24).
Sample sizes ranged from 35(23) to 4935(4). The majority of studies
were conducted in the US or the UK. Five studies included women
only(13, 21–24) and the remaining included both men and women. Mean
ages ranged from 24.0(13) to 74.6 years(12) and mean body mass indexes
ranged from 23.2(1) to 32.9 kg/m2(26). Sixteen studies investigated adults
without diagnosed diabetes, four investigated adults with a higher risk of
developing Type 2 diabetes(10, 11, 18, 29), two investigated adults with
newly diagnosed Type 2 diabetes(8, 9) and seven did not give an adequate
description ofmetabolic health(5, 6, 12, 22, 25, 27). Three studieswere of high
quality, seventeenwere ofmoderate quality and ninewere of lowquality.
Full descriptions of included studies can be seen in Table 1.
Table 2 describes themethods used tomeasure and analyse sedentary
time in the included studies. Twenty-two studies measured sedentary
time with an Actigraph accelerometer, two used ActiTrainer(5, 6), two
used Sensewear Pro Armband(7, 27), one used Actical(4), one used
Actiheart(8) and one used Active Style Pro(19). All of the studies analysed
accelerometer data as frequency counts. Twenty-three studies measured
sedentary time for 7 days, four measured it for four days(8, 10, 11, 29)
and two measured it for 8 days(2, 20). Eleven studies required at least 4
valid days of accelerometer wear time to be included in the ﬁnal analysis,
two studies used a criterion of ≥1 day(12, 28), six used ≥3 days(2, 9–11, 20,
29), three used ≥5 days(7, 14, 15), one used ≥6 days(27), one used
≥7 days(19) and ﬁve did not report any inclusion criteria for days of
wear(8, 17, 21, 23, 24). Twenty-one studies deﬁned sedentary time as b100
counts per minute (cpm), four used ≤1.5 METs(7, 8, 19, 27), one used
b150 cpm(13), one used b25 counts per 15 s(18), one used b200 cpm(28)
and one did not report how sedentary time was deﬁned(21).
Twenty-three studies presented total sedentary time as average
minutes or hours per day, three presented it as percentage of wear
time(1, 2, 26), one presented it as percentage of monitoring time(17), one
presented it as percentage of waking hours(14), one presented it as total
hours(20) and one did not report any units for total sedentary time(21).
Four of the six available studies presented breaks in sedentary time as
average number per day(4, 9, 18, 27), whilst the remaining two presented
total breaks in sedentary time(15, 16). Seventeen studies analysed total
sedentary time and/or breaks in sedentary time as continuous variables,
six analysed them as categorical variables(5, 12, 16, 20, 21, 24) and
six analysed them as both continuous and categorical variables(6, 9, 14, 15,
18, 25). Of the twelve studies that analysed total sedentary time and/or
breaks in sedentary time as categorical variables, nine used quartiles(6, 9,
12, 14–16, 20, 24, 25) and three used tertiles (5, 18, 21).Total sedentary time and cardiometabolic health
Fasting plasma glucose
There was no evidence of an association between total sedentary
time and fasting plasma glucose; thirteen of eighteen cross-sectional
analyses(3, 4, 7, 9, 11, 13, 16–18, 20, 22, 24, 27) and two of three prospective
analyses(9, 29) reported no association.
Fasting insulin
There was some evidence from cross-sectional data of an
unfavourable association between total sedentary time and fasting insu-
lin, but the evidence from prospective data was inconclusive. Nine of
twelve cross-sectional analyses reported a positive association between
total sedentary time and fasting insulin(3, 4, 6, 9, 11, 16, 23–25); six following
adjustment for MVPA(4, 6, 9, 16, 24, 25), but only one following additional
adjustment for WC(16). The remaining three analyses reported no
association(10, 13, 20).
Four studies analysed the prospective association between total
sedentary time and fasting insulin. One study reported a positive associa-
tion between baseline total sedentary time and fasting insulin at 6-month
follow-up, following adjustment for MVPA andWC(9). Another study also
reported a positive association between baseline total sedentary time and
3-year change in fasting insulin, but only in the 50% of participants who
had increased their BMI by ≥0.3 kg/m2 (MVPA was not adjusted for in
the analysis)20. The remaining two studies reported no association; one
between baseline total sedentary time and fasting insulin at 1-year
follow-up(10) and the other between 6-year change in total sedentary
time and 6-year change in fasting insulin(29).
2-Hour plasma glucose
The evidence for a cross-sectional association between total sedentary
time and 2-hour plasma glucose was inconclusive and no prospective
analyses were available. Three of six cross-sectional analyses reported a
positive association, following adjustment for MVPA, between total sed-
entary time and2-hour plasmaglucose(14, 18, 25); two following additional
adjustment for WC(14) or BMI(18). The remaining three analyses reported
no association(16, 20, 26).
HOMA-IR
There was some evidence from cross-sectional data of an
unfavourable association between total sedentary time and HOMA-IR,
but the evidence from prospective data was inconclusive. Five of
nine cross-sectional analyses reported a positive association between
Table 1
Descriptions of all the studies included in the systematic review.
ReferenceSN Exposure(s) Outcome(s) Variables adjusted for in the analysis Cross-secti al
or prospec e?
Population (n [sex], age [M ± SD], country, BMI
[M ± SD], metabolic health)
Quality
score
Socio-demographic Medical history Behaviour
Aadland
et al.
(2013)1
ST (% valid wear time) TC (mmol/L)
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)⁎
Sex, age, WC Diet Cross-secti al 78 (58% ♀), 40.7 ± 10.9 (♂) and 40.4 ± 10.6
years (♀), Norway, 25.2 ± 3.2 (♂) and 23.2 ±
2.2 kg/m2 (♀), not diagnosed with T2DM
3
Balkau et al.
(2008)2
ST (% wear time) IS (μmol/min/kgFFM/nmol/L)⁎ Age, sex, recruitment centre Total activity, LPA, activity
intensity
Cross-secti al 801 (57% ♀), 43 ± 9 (♂) and 45 ± 8 years (♀),
Europe, 25.9 ± 3.1 (♂) and 24.4 ± 4.1 kg/m2
(♀), not diagnosed with DM
2
Buman et al.
(2014)3
ST (30 min/d) FPG (mmol/L)⁎
FI (pmol/L)⁎
HOMA-%S⁎
HDL-C (mmol/L)⁎
LDL-C (mmol/L)⁎
TG (mmol/L)⁎
Age, sex, ethnicity, marital
status, education, work
status, poverty
Depressive symptoms, general
health rating, previous diagnosis
of cancer/malignancy, CVD or
diabetes, current diabetic,
antihypertensive, lipidemic or
other CVD medications
Smoking, EI, saturated fat,
caffeine, alcohol use, sleep
duration, LPA, MVPA
Cross-secti al 2187 (52% ♀), 46.6 ± 18.4 years, US, 6.3%
diagnosed with DM, mean BMI not reported
3
Carson et al.
(2014)4
ST (h/d)
BST (10/d)
FPG (mmol/L)⁎
FI (pmol/L)⁎
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, income, survey
cycle
Blood pressure medication,
medical history of Type 2 diabetes,
heart disease or cancer
Smoking, alcohol use, MVPA,
ST
Cross-secti al 4935 (50% ♀), 45.9 ± 15.1 years, Canada, 5%
diagnosed with T2DM, mean BMI not reported
2
Celis-Morales
et al.
(2011)5
ST (min/d) HOMA-IR⁎ Age, sex, environment,
socio-economic level,
education level, BMI, WC,
body fat
Smoking status, accelerometer
wear time, MVPA, ﬁtness EI
Cross-secti al 472 (63% ♀), Chile, not taking any diabetes
medication, mean age and BMI not reported
3
Celis-Morales
et al.
(2012)6
ST (100 min/d and
min/d)
FPG (mmol/L)
FI (mU/L)
HOMA-IR
TC (mmol/L)
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)
Age, sex, ethnicity,
environment, SES
Smoking status, MVPA Cross-secti al 317 (56% ♀), 37.5 ± 12.8 years, Chile, 29.2 ± 5.1
kg/m2, not taking any diabetes medication
3
Chase et al.
(2014)7
ST (min/d) FPG (mmol/L)⁎
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)⁎
Cross-secti al 50 (54% ♀), 71.5 ± 0.6 years, Canada, 24.2 ± 0.4
kg/m2, not diagnosed with DM
2
Cooper et al.
(2014)8
ST (h/d) HDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, intervention group,
occupational socioeconomic
class, WC
Use of lipid-lowering drugs Smoking status, sleep duration,
EI, % of energy from fat, alcohol
intake, MVPA
Cross-secti al 394 (37% ♀), 60.2 ± 7.4 (♂) and 60.5 ± 7.4
years (♀), UK, 31.6 ± 5.1 (♂) and 32.9 ± 6.0
kg/m2 (♀), newly diagnosed T2DM
4
Cooper et al.
(2012)9
ST (h/d)
BST (#/d)
FPG (mmol/L)
FI (pmol/L)
HOMA-IR
HDL-C (mmol/L)
Age, sex, deprivation score,
WC
Family history of diabetes,
relevant lipid- and
glucose-lowering medication
Smoking, accelerometer wear
time, MVPA, ST, BST
Prospective 528 (35% ♀), 59.8 ± 10.0 years, UK, 31.5 ± 5.6
kg/m2, newly diagnosed T2DM
5
Ekelund
et al.
(2009)10
ST (min/d) FI (pmol/L)⁎
HOMA-IR⁎
Age, sex, WC, baseline FI,
baseline HOMA-IR
Smoking status, follow-up time Prospective 192 (58% ♀), UK, 28.3 ± 4.5 (♂) and 27.5 ± 5.0
kg/m2 (♀), parental history of T2DM, mean age
not reported
3
Ekelund
et al.
(2007)11
ST (min/d) FPG (mmol/L)
FI (mol/L)⁎
HDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, WC Cross-secti al 258 (60% ♀), 40.9 ± 6.4 (♂) and 40.7 ± 6.4
years (♀), UK, 28.4 ± 4.6 (♂) and 27.4 ± 5.1
kg/m2, parental history of T2DM
3
Gennuso
et al.
(2013)12
ST (h/d) FPG (mg/dL)⁎
TC (mg/dL)
HDL-C (mg/dL)⁎
LDL-C (mg/dL)
TG (mg/dL)⁎
Age, sex, ethnicity, education,
income, marital status, BMI
CVD Alcohol consumption, current
smoking status, accelerometer
wear time, MVPA
Cross-secti al 1914 (48% ♀), 74.6 ± 6.5 years, US,mean BMI
and diabetes status not reported
4
Green et al.
(2014)13
ST (min/d) FPG (mmol/L)
FI (pmol/L)⁎
HOMA-IR⁎
TC (mmol/L)
Body mass, fat mass, fat-free
mass
MVPA, VO2peak Cross-secti al 50 women, 24.0 ± 4.8 years, US, 27.0 ± 4.8
kg/m2, not diagnosed with DM
3
(continued on next page) 95
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Table 1 (continued)
ReferenceSN Exposure(s) Outcome(s) Variables adjusted for in the analysis Cross-se ional
or prosp tive?
Population (n [sex], age [M ± SD], country, BMI
[M ± SD], metabolic health)
Quality
score
Socio-demographic Medical history Behaviour
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)⁎
Healy et al.
(2007)14
ST (h/d and % waking
hours)
FPG (mmol/L)
2hPG (mmol/L)
Age, sex, height, WC,
education, income
Family history of diabetes Time accelerometer worn,
accelerometer unit, alcohol
intake, smoking status, MVPA
Cross-se ional 173 (61% ♀), 53.3 years, Australia, 27.2 kg/m2,
2% newly diagnosed DM
4
Healy et al.
(2008a)15
BST (total) FPG (mmol/L)
2hPG (mmol/L)
HDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, employment,
income, education
Family history of diabetes,
lipid-lowering medication
Alcohol intake, smoking, diet
quality, MVPA, mean intensity
of breaks, ST
Cross-se ional 168, 53.4 ± 11.8 years, Australia, 27.2 ± 4.7
kg/m2, not diagnosed with DM, percentage fe-
male not reported
2
Healy et al.
(2011)16
ST (h/d)
BST (total)
FPG (mmol/L)⁎
FI (pmol/L)⁎
2hPG (mmol/L)⁎
HOMA-%S⁎
HDL-C (mmol/L)⁎
TG (mmol/L)⁎
Age, sex, ethnicity, education,
height, marital status,
poverty-to-income ratio, WC
Diabetes, cancer,
anti-hypertensive medication,
other CVD medications, family
history of CHD, family history of
diabetes, CVD history, lipidemic
medication
MVPA, ST, smoking, %
saturated fat, alcohol intake, EI,
potassium, caffeine
Cross-se ional 4757 (50% ♀), 46.5 ± 14.2 years, US, 7.5%
diagnosed with DM or borderline DM, mean BMI
not reported
4
Healy et al.
(2008b)17
ST (% monitoring
time)
FPG (mmol/L)
HDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, employment status,
income, education,
Family history of diabetes,
lipid-lowering medication
Alcohol intake, smoking status,
diet quality, MVPA
Cross-se ional 169 (60%♀), 53.4 years, Australia, not diagnosed
with DM, mean BMI not reported
1
Henson et al.
(2013)18
ST (h/d)
BST (#/d)
FPG (mmol/L)⁎
2hPG (mmol/L)⁎
HDL-C (mmol/L)⁎
TG (mmol/L)⁎
Age, sex, ethnicity, social
deprivation, BMI
Family history of Type 2 diabetes,
beta-blockers, lipid-lowering
medication
Smoking status, time
accelerometer worn, MVPA, ST
Cross-se ional 878 (41% ♀), 58.4 ± 13.8 years, UK, 32.5 ± 5.2
kg/m2, with known risk factors for T2DM
5
Kim et al.
(2013)19
ST (h/d) FPG (mg/dL)
HDL-C (mg/dL)
TG (mg/dL)
Age, sex Smoking status, calorie intake,
accelerometer wear time,
MVPA
Cross-se ional 483 (63% ♀), 47.9 ± 9.0 years, Japan, 25.6 ± 4.0
kg/m2, not diagnosed with DM
4
Lahjibi et al.
(2013)20
ST (h) FPG (mmol/L)
FI (pmol/L)⁎
2hPG (mmol/L)
HOMA-IR⁎
IS (μmol/min/kgFFM/nmol/L)⁎
TC (mmol/L)
HDL-C (mmol/L)
LDL-C (mmol/L)
TG (mmol/L)⁎
Age, sex, recruiting centre MVPA Prospect e 727 (57% ♀), 43 ± 9 (♂) and 45 ± 8 years (♀),
Europe, 25.8 ± 3.1 (♂) and 24.3 ± 4.0 kg/m2
(♀), not diagnosed with DM
4
LeCheminant
and Tucker
(2011)21
ST (units not
reported)
HOMA-IR Age, weight, BMI, body fat %,
abdominal circumference
Cross-se ional 264 women, 40.1 ± 3.0 years, US, 23.8 ± 3.3
kg/m2, healthy (PAR-Q)
2
Loprinzi
et al.
(2013)22
ST (min/d) FPG (mg/dL)
TC (mmol/L)
HDL-C (mg/dL)
LDL-C (mg/dL)
TG (mg/dL)
Age, education, marital
status, poverty-to-income
ratio, ethnicity, BMI
Gestation Smoking, MVPA Cross-se ional 206 pregnant women, 28.4 years, US, 29.2
kg/m2, diabetes status not reported
4
Lynch et al.
(2010)23
ST (h/d) FI (pmol/L)⁎ Age, ethnicity MVPA Cross-se ional 111 women — 35 in FI analysis, 69.2 ± 13.0
years, US, 27.6 ± 6.4 kg/m2, 24.3% diagnosed
with DM or borderline DM
4
Lynch et al.
(2011)24
ST (h/d) FPG (mmol/L)⁎
FI (pmol/L)⁎
HOMA-IR⁎
Age, marital status, annual
family income, ethnicity, WC
Age at last period, years of
hormone replacement therapy
use, age at ﬁrst birth
MVPA, alcohol intake, smoking
status
Cross-se ional 467 postmenopausal women, 62.4 ± 9.5 years,
US, 27.1 kg/m2, not diagnosed with DM
5
Maher et al.
(2014)25
ST (h/d and min/d) FPG (mmol/L)⁎
FI (pmol/L)⁎
2hPG (mmol/L)⁎
HOMA-%S⁎
HDL-C (mmol/L)⁎
TG (mmol/L)⁎
Age-squared, educational
attainment,
poverty-to-income ratio
Relative with diabetes, CVD
medication, diabetes medication,
ever been told cancer, ever been
told diabetes, ever been told CVD,
hypertension medication,
lipidemic medication
Accelerometer wear time,
smoking status, % saturated fat,
alcohol intake, EI, MVPA, total
physical activity
Cross-se ional 4618 (48% ♀), US, 28.2 (♂) and 28.0 kg/m2 (♀),
mean age and diabetes status not reported
2
McGuire and
Ross
(2011)26
ST⁎ (min/d and %
wear time)
2hPG (mmol/L)
HOMA-IR⁎
TC (mmol/L)
HDL-C (mmol/L)⁎
Sex, age, WC Time accelerometer worn, LPA,
MVPA
Cross-se ional 135 (68% ♀), 53.1 ± 7.6 years, Canada, 32.9 ±
4.6 kg/m2, not diagnosed with DM
4
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97L.A. Brocklebank et al. / Preventive Medicine 76 (2015) 92–102total sedentary time and HOMA-IR(5, 6, 9, 21, 24); four following
adjustment for MVPA(5, 6, 9, 24), but only one following additional
adjustment for BMI and WC(5). The remaining four analyses reported
no association(10, 13, 20, 26).
Three studies analysed the prospective association between total
sedentary time and HOMA-IR. One study reported a positive association
between baseline total sedentary time and HOMA-IR at 6-month
follow-up, following adjustment for MVPA and WC(9). Another study
also reported a positive association between baseline total sedentary
time and 3-year change in HOMA-IR, but only in the 50% of participants
who had increased their BMI by ≥0.3 kg/m2 (MVPA was not adjusted
for in the analysis)20. The remaining study reported no association
between baseline total sedentary time and HOMA-IR at 1-year follow-
up(10).
Insulin sensitivity
There was consistent evidence from cross-sectional data of an
unfavourable association between total sedentary time and insulin
sensitivity. All of the ﬁve available cross-sectional analyses reported
a negative association between total sedentary time and insulin
sensitivity(2, 3, 16, 20, 25); three following adjustment for MVPA(16, 20, 25),
but only one following additional adjustment for WC(16). However, to
our knowledge, no studies to date have analysed the prospective associa-
tion between accelerometer-measured total sedentary time and insulin
sensitivity.
Total cholesterol
There was no evidence of an association between total sedentary
time and total cholesterol; six of eight cross-sectional analyses reported
no association(1, 12, 13, 20, 22, 26) and no prospective analyses were
available.
HDL-cholesterol
The evidence for an association between total sedentary time and
HDL-cholesterol was inconclusive. Eleven of twenty cross-sectional
analyses reported no association between total sedentary time and
HDL-cholesterol(1, 3, 4, 7, 11–13, 17, 22, 26, 28). The remaining nine analyses
reported a negative association(6, 8, 9, 16, 18–20, 25, 27); eight following
adjustment for MVPA(6, 8, 9, 16, 18–20, 25), but only four following
additional adjustment for WC(8, 9, 16) or BMI(18). Two studies analysed
the prospective association between total sedentary time and HDL-
cholesterol; one reported a negative association, following adjustment
for MVPA and WC, between baseline total sedentary time and HDL-
cholesterol at 6-month follow-up(9), whilst the other reported no associ-
ation between 6-year change in total sedentary time and 6-year change
in HDL-cholesterol(29).
LDL-cholesterol
There was no evidence of an association between total sedentary
time and LDL-cholesterol; six of nine cross-sectional analyses reported
no association(1, 3, 4, 12, 13, 20) and no prospective analyses were
available.
Triglycerides
There was some evidence from both cross-sectional and prospective
data of an unfavourable association between total sedentary time and
triglycerides. Twelve of eighteen cross-sectional analyses reported a pos-
itive association between total sedentary time and triglycerides(1, 3, 6, 8,
13, 16–20, 25, 27); nine following adjustment for MVPA(6, 8, 13, 16–20, 25),
but only three following additional adjustment for WC(8, 16) or BMI(18).
The remaining six analyses reported no association(4, 7, 11, 12, 22, 26). The
Table 2
Descriptions of the methods used to measure and analyse sedentary time in the included studies.
Study
number
Exposure(s) Device Monitoring
period (days)
Accelerometer inclusion
criteria
How was
sedentary time
deﬁned?
Was sedentary
time analysed
as frequency
counts?
Effect measure(s)
1 ST (% valid wear time) Actigraph GT1M or GT3X+ 7 ≥10 h/d for ≥4 d b100 cpm Yes Pearson
2 ST (% wear time) Actigraph AM7164-2.2 8 N10 h/d for ≥3 d b100 cpm Yes Regression
3 ST (30 min/d) Actigraph 7164 7 ≥10 h/d for ≥4 d b100 cpm Yes Regression
4 ST (h/d)
BST (10/d)
Actical 7 ≥10 h/d for ≥4 d (including 1 weekend day) b100 cpm Yes Regression
5 ST (min/d) ActiTrainer 7 ≥10 h/d for ≥4 d b100 cpm Yes Ptrend (tertiles)
6 ST (100 min/d and min/d) ActiTrainer 7 ≥10 h/d for ≥4 d b100 cpm Yes Regression and Ptrend (quartiles)
7 ST (min/d) Sensewear Pro Armband 7 ≥21 h/d for ≥5 d b1.5 METs Yes Pearson
8 ST (h/d) Actiheart 4 Not reported b1.5 METs Yes Regression
9 ST (h/d)
BST (#/d)
Actigraph GT1M 7 N10 h/d for ≥3 d b100 cpm Yes Regression and Ptrend (quartiles)
10 ST (min/d) Actigraph 7164 4 ≥500 min/d for ≥3 d b100 cpm Yes Regression
11 ST (min/d) Actigraph 7164 4 ≥500 min/d for ≥3 d b100 cpm Yes Regression (standardised)
12 ST (h/d) Actigraph AM-7164 7 ≥10 h/d for ≥1 d b100 cpm Yes Ptrend (quartiles)
13 ST (min/d) Actigraph GT3X+ 7 ≥10 h/d for ≥4 d (including 1 weekend day) b150 cpm Yes Pearson and regression (standardised)
14 ST (h/d and % waking hours) Actigraph 7164 7 ≥10 h/d for ≥5 d (including ≥1 weekend day) b100 cpm Yes Regression and Ptrend (quartiles)
15 BST (total) Actigraph 7164 7 ≥10 h/d for ≥5 d (including ≥1 weekend day) b100 cpm Yes Regression (standardised) and Ptrend (quartiles)
16 ST (h/d)
BST (total)
Actigraph 7164 7 ≥10 h/d for ≥4 d (including ≥1 weekend day) b100 cpm Yes Ptrend (quartiles)
17 ST (% monitoring time) Actigraph 7164 7 Not reported b100 cpm Yes Regression (standardised)
18 ST (h/d)
BST (#/d)
Actigraph GT3X 7 ≥10 h/d for ≥4 d b25 counts per 15 s Yes Regression (standardised) and Ptrend (tertiles)
19 ST (h/d) Active Style Pro (HJA-350IT) 7 ≥10 h/d for 7 d ≤1.5 METs Yes Regression
20 ST (h) Actigraph AM7164-2.2 8 N10 h/d for ≥3 d b100 cpm Yes Ptrend (quartiles)
21 ST (units not reported) Actigraph 7 Not reported Not reported Yes Ptrend (tertiles)
22 ST (min/d) Actigraph 7164 7 ≥10 h/d for ≥4 d b100 cpm Yes Regression
23 ST (h/d) Actigraph 7164 7 ≥10 h/d b100 cpm Yes Regression
24 ST (h/d) Actigraph 7164 7 ≥10 h/d b100 cpm Yes Ptrend (quartiles)
25 ST (h/d and min/d) Actigraph 7164 7 ≥10 h/d for ≥4 d (including ≥1 weekend day) b100 cpm Yes Regression and Ptrend (quartiles)
26 ST (min/d and % wear time) Actigraph GT3X 7 ≥10 h/d for ≥4 d (including 1 weekend day) b100 cpm Yes Regression
27 ST (h/d)
BST (#/d)
Sensewear Pro 3 Armband 7 ≥1368 min/d for ≥6 d (including Saturday and Sunday) ≤1.5 METs Yes Pearson
28 ST (10 min/d) Actigraph GT1M 7 ≥10 h/d for ≥1 d 0–199 cpm Yes Regression
29 ST (h/d) Actigraph 4 N500 min/d for ≥3 d b100 cpm Yes Regression
ST, total sedentary time; BST, breaks in sedentary time; %, percentage; min, minute(s); h, hour(s); #, number; d, day(s); cpm, counts per minute; s, second(s); METs, metabolic equivalents.
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99L.A. Brocklebank et al. / Preventive Medicine 76 (2015) 92–102one available prospective analysis reported a positive association, follow-
ing adjustment forMVPA, between6-year change in total sedentary time
and 6-year change in triglycerides (neither BMI norWCwas adjusted for
in the analysis)29.
Overview of ﬁndings
For each cardiometabolic biomarker, an overviewofﬁndings,method-
ological quality scores and sample sizes are presented in Table 3. There
was consistent evidence from cross-sectional data of an unfavourable
association between total sedentary time and insulin sensitivity.
Therewas also some evidence that total sedentary timewasunfavourably
associated with fasting insulin, HOMA-IR and triglycerides. The majority
of analyses adjusted for MVPA, with unfavourable associations surviving
this adjustment. However, fewer analyses additionally adjusted for
BMI and/or WC. The evidence for associations of total sedentary time
with 2-hour plasma glucose and HDL-cholesterol was inconclusive and
there was no evidence of associations with fasting plasma glucose, total
cholesterol or LDL-cholesterol.
Breaks in sedentary time and cardiometabolic health
Fasting plasma glucose
Therewas no evidence of an association between breaks in sedentary
time and fasting plasma glucose; ﬁve of six cross-sectional analyses(9, 15,
16, 18, 27) and the one available prospective analysis(9) reported no
association.
Fasting insulin
Therewas no evidence of an association between breaks in sedentary
time and fasting insulin; two of three cross-sectional analyses(9, 16) and
the one available prospective analysis(9) reported no association.Table 3
Cross-sectional and prospective associations of accelerometer-measured total sedentary time w
sample sizes.
*, listed twice because different ﬁndings were reported depending on whether total sedentary
ﬁndingswere reporteddepending onbodymass index (BMI) strata. a, association survived adjus
adjustment for BMI and/or waist circumference (WC). Dark shading= positive association; lig
glucose; FI, fasting insulin; 2hPG, 2-hour plasma glucose; HOMA-IR, homeostasis model assessm
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; X, cross-se
0–7, higher score indicates better quality); SN, study number; N, sample size.2-Hour plasma glucose
The evidence for a cross-sectional association between breaks
in sedentary time and 2-hour plasma glucose was inconclusive and
no prospective studies were available. One study reported a negative
association between breaks in sedentary time and 2-hour plasma
glucose, following adjustment for MVPA and total sedentary time, but
the association did not survive additional adjustment for BMI(18).
Another study also reported a negative association, following adjust-
ment for MVPA and total sedentary time, when breaks in sedentary
time were analysed as a continuous variable, but no association when
2-hour plasma glucose was compared across quartiles of breaks in
sedentary time (neither BMI norWCwas adjusted for in the analyses)15.
The remaining study reported no association(16).
HOMA-IR
There was no evidence of an association between breaks in sedentary
time and HOMA-IR in the one available prospective study(9).
Insulin sensitivity
There was no evidence of an association between breaks in sedentary
time and insulin sensitivity in the one available cross-sectional study(16).
HDL-cholesterol
The evidence for an association between breaks in sedentary time and
HDL-cholesterol was inconclusive. Two of six cross-sectional analyses
reported a positive association between breaks in sedentary time and
HDL-cholesterol(4, 18); one following adjustment for MVPA and total
sedentary time(4), but none following additional adjustment for BMI or
WC. Another study also reported a positive association, following adjust-
ment forMVPA, total sedentary time andWC, when HDL-cholesterol wasith cardiometabolic biomarkers: overview of ﬁndings, methodological quality scores and
time was analysed as a continuous or categorical variable. #, listed twice because different
tment formoderate-to-vigorous-intensity physical activity (MVPA). b, association survived
ht shading= no association; medium shading= negative association. FPG, fasting plasma
ent of insulin resistance; IS, insulin sensitivity; TC, total cholesterol; HDL-C, high-density
ctional association; P, prospective association; quality, methodological quality score (range
100 L.A. Brocklebank et al. / Preventive Medicine 76 (2015) 92–102compared across quartiles of breaks in sedentary time, but no association
when breaks in sedentary timewere analysed as a continuous variable(9).
The remaining three analyses reported no association(15, 16, 27). The one
available prospective analysis reported no association between the num-
ber of breaks in sedentary time at baseline and HDL-cholesterol at 6-
month follow-up(9).
LDL-cholesterol
There was no evidence of an association between breaks in sedentary
time and LDL-cholesterol in the one available cross-sectional study(4).
Triglycerides
There was some evidence from cross-sectional data of a favourable
association between breaks in sedentary time and triglycerides. Three
of ﬁve cross-sectional studies reported a negative association between
breaks in sedentary time and triglycerides(4, 15, 18); two following
adjustment forMVPA and total sedentary time(4, 15), but none following
additional adjustment for BMI orWC. The remaining two studies reported
no association(16, 27). However, to our knowledge, no studies to date have
analysed the prospective association between accelerometer-measured
breaks in sedentary time and triglycerides.
Overview of ﬁndings
For each cardiometabolic biomarker, an overviewofﬁndings,method-
ological quality scores and sample sizes are presented in Table 4. There
was some evidence from cross-sectional data of a favourable association
between breaks in sedentary time and triglycerides. The majority of
studies reported a favourable association following adjustment for
MVPAand total sedentary time, but none following additional adjustment
for BMI and/or WC. The evidence for associations of breaks in sedentary
time with 2-hour plasma glucose and HDL-cholesterol was inconclusiveTable 4
Cross-sectional and prospective associations of accelerometer-measured breaks in sedentary
time with cardiometabolic biomarkers: overview of ﬁndings, methodological quality scores
and sample sizes.
*, listed twice because different ﬁndings were reported depending on whether breaks
in sedentary time were analysed as a continuous or categorical variable. a, association
survived adjustment for moderate-to-vigorous-intensity physical activity (MVPA) and
total sedentary time. Dark shading=positive association; light-shading=no association;
medium shading = negative association. FPG, fasting plasma glucose; FI, fasting insulin;
2hPG, 2-hour plasma glucose; HOMA-IR, homeostasis model assessment of insulin
resistance; IS, insulin sensitivity; HDL-C, high-density lipoprotein cholesterol; LDL-C,
low-density lipoprotein cholesterol; TG, triglycerides; X, cross-sectional association;
P, prospective association; quality, methodological quality score (range 0–7, higher
score indicates better quality); SN, study number; N, sample size.and there was no evidence of associations with fasting plasma glucose,
fasting insulin, HOMA-IR, insulin sensitivity or LDL-cholesterol.
Discussion
The current systematic review investigated the cross-sectional and
prospective associations of accelerometer-measured total sedentary
time and breaks in sedentary time with individual cardiometabolic bio-
markers in adults≥18 years of age. There was consistent evidence from
ﬁve cross-sectional analyses of an unfavourable association between
total sedentary time and insulin sensitivity. Three of these associations
survived adjustment for MVPA, but only one analysis additionally
adjusted for WC. There was also some evidence that total sedentary
time was unfavourably associated with fasting insulin, HOMA-IR and
triglycerides. Furthermore, there was some evidence from three out of
ﬁve cross-sectional studies of a favourable association between breaks
in sedentary time and triglycerides. Two of these associations survived
adjustment for MVPA and total sedentary time, but none survived
additional adjustment for BMI or WC.
A previous meta-analysis reported that the risk of Type 2 diabetes
was 112% greater in adults with the highest compared to the lowest
self-reported sedentary time (Wilmot et al., 2012). Insulin resistance
is a precursor to Type 2 diabetes and thus, this ﬁnding supports the
consistent, unfavourable association between total sedentary time and
insulin sensitivity that was reported in the current review. An
unfavourable association between total sedentary time and insulin
sensitivity was mostly reported after adjusting for MVPA, which
suggests that this association is not entirely mediated by a decrease in
the amount of time spent in MVPA. The physiological mechanism(s) by
which sedentary behaviour adversely affects insulin sensitivity are
currently debated, but potential mechanisms include a reduction in
contraction-stimulated capillary recruitment and/or glucose transporter
4 (GLUT4) translocation (Hamburg et al., 2007; Lund et al., 1995).
A recent systematic review investigated the cross-sectional associa-
tions between sedentary time and individual cardiometabolic biomarkers
in adults≥60 years of age, showing unfavourable associations with HDL-
cholesterol, but not triglycerides (de Rezende et al., 2014). These ﬁndings
do not support the unfavourable association between total sedentary
time and triglycerides that was reported in the current review. However,
only three studies reported on triglycerides in the review by de Rezende
et al. (2014); two measured sedentary time with a self-report question-
naire andonewas evaluated as very lowquality. In contrast, in the current
review, nineteen studies (including one prospective study) analysed
the association between total sedentary time and triglycerides; all of
the studies measured total sedentary time with an accelerometer and
fourteen were evaluated as moderate-to-high quality.
Another explanation for why the two reviews reported different
ﬁndings could be that the association between sedentary time and
cardiometabolic health is different among younger (≥18 years of age)
and older (≥60 years of age) adults. Nybo et al. (2003) previously
reported that smoking, obesity and alcohol consumption were less
predictive of mortality in older adults (≥75 years of age) (Nybo et al.,
2003). In support of this, three studies included in the current review
analysed the cross-sectional association between total sedentary time
and triglycerides in older adults (mean age≥60 years) and two reported
no association. The association between total sedentary time and triglyc-
erides may have differed by age because older adults tend to have a
poorer cardiometabolic proﬁle or because older adults tend to spend
more time in sedentary behaviours (de Rezende et al., 2014).
The physiological mechanism(s) by which sedentary behaviour
adversely affects triglycerides are currently poorly understood. However,
an experimental study conducted in rats suggests that it could be due to
a reduction in skeletal muscle lipoprotein lipase (LPL) activity (Bey and
Hamilton, 2003).
To our knowledge, the current review is the ﬁrst to investigate the
association between breaks in sedentary and cardiometabolic health
101L.A. Brocklebank et al. / Preventive Medicine 76 (2015) 92–102and provides some evidence of a favourable association between breaks
in sedentary time and triglycerides. A favourable associationwasmostly
reported following adjustment for MVPA and total sedentary time, sug-
gesting that the health beneﬁts associated with regularly breaking up
sedentary time are additional to those associated with increasing time
spent in MVPA and reducing total sedentary time.
Study strengths and limitations
Themain strength of the current systematic review is that it only in-
cludes studies that used an accelerometer to measure total sedentary
time and/or breaks in sedentary time. This is in contrast to previous re-
views which have relied on self-report questionnaires (de Rezende
et al., 2014; Edwardson et al., 2012; Wilmot et al., 2012). Self-report
questionnaires provide information on the type of sedentary behaviours
being undertaken and the social and environmental contexts in which
they occur, which is useful for choosing which behaviour(s) to target
during public health interventions (Atkin et al., 2012; Corder et al.,
2007, 2008). However, they are vulnerable to recall and social desirabil-
ity bias, making them less suitable for use during association studies
(Clark et al., 2009; Corder et al., 2007). Accelerometers are currently
the most valid and reliable tool for measuring sedentary time (de
Rezende et al., 2014). However, hip-mounted accelerometers, such as
the Actigraph accelerometer, are incapable of distinguishing between
postures. Consequently, time spent standing may be misclassiﬁed as
sedentary time, resulting in an overestimation of total sedentary time
(Clemes et al., 2012). Future association studies should consider using
the activPAL accelerometer to measure sedentary time. The activPAL
accelerometer is worn on the thigh and uses information about thigh
inclination to estimate the amount of time spent sitting or lying,
standing and walking (Atkin et al., 2012; Ryan et al., 2006).
Another strength of the current review is that it investigates individual
cardiometabolic biomarkers rather than global measures of cardiometa-
bolic health, such as risk of Type 2 diabetes and CVD (Wilmot et al.,
2012) or clustered metabolic risk (Edwardson et al., 2012). Global
measures may be more important to patients and clinicians, but individ-
ual biomarkers allow a better understanding of the sedentary behaviour
physiology, which is currently poorly understood (de Rezende et al.,
2014).
The majority of studies included in the current review investigated
adults without diagnosed diabetes, but other populations were also
investigated. Individuals with Type 2 diabetes or with a higher risk of
developing Type 2 diabetes are different from healthy individuals
because they have a poorer cardiometabolic proﬁle. In addition, they
may spend more time in sedentary behaviours and less in MVPA.
Despite this, the different populations showed similar associations,
suggesting that the ﬁndings are generalisable. However, only six studies
investigated adults with newly diagnosed Type 2 diabetes or with a
higher risk of developing Type 2 diabetes and therefore, future studies
should investigate further whether the relationship between sedentary
behaviour and cardiometabolic health differs by the presence or
absence of Type 2 diabetes.
The main limitation of the current review is that it was not possible
to conduct a meaningful meta-analysis due to inconsistencies in the
way in which sedentary time was measured, deﬁned and analysed.
For example, different accelerometer cut points were used to deﬁne
sedentary time. The majority of studies deﬁned sedentary time as
b100 cpm, which has been shown to underestimate total sedentary
time by 16.9 min (Kozey-Keadle et al., 2011). Kozey-Keadle et al.
(2011) found that the cut point with the lowest bias was 150 cpm, but
only one study used this cut point in the current review (Green et al.,
2014). Cut points greater than 150 cpm have been shown to overesti-
mate total sedentary time, probably due to misclassiﬁcation of time
spent in light-intensity physical activity as sedentary time. To improve
comparability between studies in the future, methods of measuring
and deﬁning sedentary time need to be standardised. Furthermore, toaid data synthesis, future association studies should report the unit
change in each cardiometabolic biomarker per 1-hour increase in total
sedentary time and/or 1-break increase in breaks in sedentary time.
Another limitation of the current review is that only one study
required at least 7 valid days of accelerometer wear time to be included
in the ﬁnal analysis (Kim et al., 2013), suggesting that current studies
have undersampled total sedentary time (Matthews et al., 2002).
Causality cannot be inferred from the ﬁndings of the current review
because only four studies were prospective. Furthermore, we cannot
rule out the possibility that physical inactivity and/or obesity at least
partially mediated the reported associations because not all of the
studies adjusted for MVPA plus BMI and/or WC.
Conclusion
In conclusion, therewas consistent evidence from cross-sectional data
that accelerometer-measured total sedentary time was unfavourably
associated with insulin sensitivity, supporting a detrimental association
between self-reported sedentary time and risk of Type 2 diabetes that
was reported in a previous meta-analysis. There was also some evidence
that total sedentary time was unfavourably associated with fasting insu-
lin, HOMA-IR and triglycerides. Finally, there was some evidence from
cross-sectional data that accelerometer-measured breaks in sedentary
time were favourably associated with triglycerides. However, further
studies are required to investigate the prospective associations of
accelerometer-measured total sedentary time and breaks in sedentary
time with individual cardiometabolic biomarkers. Consistent methods of
measuring, deﬁning and analysing sedentary time should also be used
to enable comparison between such studies. Nonetheless, data presented
here support the suggestion that greater volumes of sedentary time are
detrimental to health and reinforce the need to identify interventions to
reduce time spent sedentary.
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